![IUCr) Psilacetin derivatives: fumarate salts of the methyl–ethyl, methyl–allyl and diallyl variants of the psilocin prodrug IUCr) Psilacetin derivatives: fumarate salts of the methyl–ethyl, methyl–allyl and diallyl variants of the psilocin prodrug](https://journals.iucr.org/e/issues/2021/02/00/hb7959/hb7959largethumb.jpg)
IUCr) Psilacetin derivatives: fumarate salts of the methyl–ethyl, methyl–allyl and diallyl variants of the psilocin prodrug
![Psilacetin derivatives: fumarate salts of the methyl–ethyl, methyl–allyl and diallyl variants of the psilocin prodrug - ScienceDirect Psilacetin derivatives: fumarate salts of the methyl–ethyl, methyl–allyl and diallyl variants of the psilocin prodrug - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2056989022004133-e-77-00101-fig5.jpg)
Psilacetin derivatives: fumarate salts of the methyl–ethyl, methyl–allyl and diallyl variants of the psilocin prodrug - ScienceDirect
![MicroRNA-206 suppresses mesothelioma progression via the Ras signaling axis: Molecular Therapy - Nucleic Acids MicroRNA-206 suppresses mesothelioma progression via the Ras signaling axis: Molecular Therapy - Nucleic Acids](https://www.cell.com/cms/attachment/ee4a9b45-9d59-403a-bdf3-08acabb6a9bb/fx1_lrg.jpg)
MicroRNA-206 suppresses mesothelioma progression via the Ras signaling axis: Molecular Therapy - Nucleic Acids
![4-acetoxy DMT (fumarate) (4-acetoxy-N,N-Dimethyltryptamine, O-Acetylpsilocin, Psilacetin, CAS Number: 1217230-42-6) | Cayman Chemical 4-acetoxy DMT (fumarate) (4-acetoxy-N,N-Dimethyltryptamine, O-Acetylpsilocin, Psilacetin, CAS Number: 1217230-42-6) | Cayman Chemical](https://www.caymanchem.com/images/catalog/screen/35188.png)
4-acetoxy DMT (fumarate) (4-acetoxy-N,N-Dimethyltryptamine, O-Acetylpsilocin, Psilacetin, CAS Number: 1217230-42-6) | Cayman Chemical
![Safety and efficacy of stopping tenofovir disoproxil fumarate in patients with chronic hepatitis B following at least 8 years of therapy: a prespecified follow-up analysis of two randomised trials - The Lancet Safety and efficacy of stopping tenofovir disoproxil fumarate in patients with chronic hepatitis B following at least 8 years of therapy: a prespecified follow-up analysis of two randomised trials - The Lancet](https://www.thelancet.com/cms/attachment/2fe24897-261c-47cb-b424-05d46d590495/gr1.gif)
Safety and efficacy of stopping tenofovir disoproxil fumarate in patients with chronic hepatitis B following at least 8 years of therapy: a prespecified follow-up analysis of two randomised trials - The Lancet
![Discovery of Pyrrolopyridine−Pyridone Based Inhibitors of Met Kinase: Synthesis, X-ray Crystallographic Analysis, and Biological Activities | Journal of Medicinal Chemistry Discovery of Pyrrolopyridine−Pyridone Based Inhibitors of Met Kinase: Synthesis, X-ray Crystallographic Analysis, and Biological Activities | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/jm800476q/asset/images/large/jm-2008-00476q_0002.jpeg)
Discovery of Pyrrolopyridine−Pyridone Based Inhibitors of Met Kinase: Synthesis, X-ray Crystallographic Analysis, and Biological Activities | Journal of Medicinal Chemistry
![TRIBUTE study shows superiority of Chiesi's Trimbow® (Beclometasone dipropionate (BDP), Formoterol fumarate (FF) and Glycopyrronium bromide (GB)) over Ultibro® in reducing COPD exacerbations1 TRIBUTE study shows superiority of Chiesi's Trimbow® (Beclometasone dipropionate (BDP), Formoterol fumarate (FF) and Glycopyrronium bromide (GB)) over Ultibro® in reducing COPD exacerbations1](https://www.chiesi.es/img/news/SWcPhgGFELLogo.jpg)
TRIBUTE study shows superiority of Chiesi's Trimbow® (Beclometasone dipropionate (BDP), Formoterol fumarate (FF) and Glycopyrronium bromide (GB)) over Ultibro® in reducing COPD exacerbations1
![Frontiers | Physiological Perspectives on the Use of Triheptanoin as Anaplerotic Therapy for Long Chain Fatty Acid Oxidation Disorders Frontiers | Physiological Perspectives on the Use of Triheptanoin as Anaplerotic Therapy for Long Chain Fatty Acid Oxidation Disorders](https://www.frontiersin.org/files/Articles/598760/fgene-11-598760-HTML-r1/image_m/fgene-11-598760-g001.jpg)
Frontiers | Physiological Perspectives on the Use of Triheptanoin as Anaplerotic Therapy for Long Chain Fatty Acid Oxidation Disorders
![Metabolic rewiring in the promotion of cancer metastasis: mechanisms and therapeutic implications | Oncogene Metabolic rewiring in the promotion of cancer metastasis: mechanisms and therapeutic implications | Oncogene](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41388-020-01432-7/MediaObjects/41388_2020_1432_Fig1_HTML.png)
Metabolic rewiring in the promotion of cancer metastasis: mechanisms and therapeutic implications | Oncogene
Risk factors for development of lymphopenia in dimethyl fumarate-treated patients with multiple sclerosis
![Metformin improves the therapeutic efficacy of low-dose albendazole against experimental alveolar echinococcosis | Parasitology | Cambridge Core Metformin improves the therapeutic efficacy of low-dose albendazole against experimental alveolar echinococcosis | Parasitology | Cambridge Core](https://static.cambridge.org/content/id/urn%3Acambridge.org%3Aid%3Aarticle%3AS0031182021001633/resource/name/S0031182021001633_figAb.png?pub-status=live)
Metformin improves the therapeutic efficacy of low-dose albendazole against experimental alveolar echinococcosis | Parasitology | Cambridge Core
![Cancers | Free Full-Text | Shifting the Gears of Metabolic Plasticity to Drive Cell State Transitions in Cancer Cancers | Free Full-Text | Shifting the Gears of Metabolic Plasticity to Drive Cell State Transitions in Cancer](https://www.mdpi.com/cancers/cancers-13-01316/article_deploy/html/images/cancers-13-01316-g001.png)
Cancers | Free Full-Text | Shifting the Gears of Metabolic Plasticity to Drive Cell State Transitions in Cancer
![Bone and ocular safety of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a 52-week randomized study | Respiratory Research | Full Text Bone and ocular safety of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a 52-week randomized study | Respiratory Research | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12931-019-1126-7/MediaObjects/12931_2019_1126_Fig1_HTML.png)